现实世界对儿童严重喘生物治疗的坚持
Steven J Rose1, Aisaku Nakamura2, Md Monir Hossain3
1Division of Pulmonary Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
The journal of allergy and clinical immunology. In practice
|September 25, 2025
概括
儿科重症喘患者表现出对生物药物的良好坚持,改善症状和肺功能. 遵守与施用方法,保险和剂量频率有关,突出了治疗成功的关键因素.
科学领域:
- 儿科肺病学 儿科肺病学
- 药理学 药理学是指药理学的学科.
- 喘管理 喘管理
背景情况:
- 生物药物对于严重的喘是有效的,但儿科坚持数据有限.
- 了解坚持对于优化严重喘儿童治疗至关重要.
研究的目的:
- 评估严重喘儿童对生物药物的坚持率.
- 识别影响喘坚持的因素及其对喘结果的影响.
主要方法:
- 对患有严重喘的儿科患者的回顾性图表审查.
- 在生物治疗的第一年对坚持的分析.
- 统计建模用于检查坚持,管理,保险,剂量和结果之间的关系.
主要成果:
- 六个月后的坚持率为84%,十二个月后的坚持率为76%.
- 给药方法,保险和剂量频率显著影响了坚持.
- 生物疗法改善了结果,导致恶化减少,并改善了螺旋计 (FVC,FEV1),这与坚持相关.
结论:
- 儿童对喘生物药物的坚持超过了吸入性皮质类固醇的坚持.
- 生物疗法改善了喘控制,坚持是这些好处的关键.
- 管理策略,保险和剂量是影响遵守的关键因素.
相关概念视频
Asthma-IV: Diagnostic and Management
3.1K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.1K
Asthma-IV: Nursing Management
3.7K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
3.7K
Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
Antiasthma Drugs: β2-Adrenoceptor Agonists
1.6K
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
1.6K
Asthma-III: Symptoms and Complications
3.3K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
3.3K
Antiasthma Drugs: Leukotriene Modifiers
1.8K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
1.8K


